top of page

MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL

Product details

Registration number: SIN17446P

Classification: Prescription Only

Active ingredients:

  • Amoxicillin sodium eqv. to Amoxicillin
  • Potassium clavulanate eqv. to Clavulanic acid

Strength:

  • 1000mg/vial
  • 200mg/vial

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS

Registrant: MEDOCHEMIE SINGAPORE PTE. LTD.

ATC code: J01CR02

HSA approval date: 27 January 2026

Manufacturer(s):

  • MEDOCHEMIE LTD (FACTORY B -INJECTABLE FACILITY)
  • ZHUHAI UNITED LABORATORIES CO, LTD. (intermediate 5:1 mixture)

Manufacturing country/countries: CYPRUS; CHINA

What are the HSA registration number and classification for MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17446P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • Amoxicillin sodium eqv. to Amoxicillin
  • Potassium clavulanate eqv. to Clavulanic acid

Strength:

  • 1000mg/vial
  • 200mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL?

According to the HSA dataset updated 7 August 2026:

Registrant: MEDOCHEMIE SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • MEDOCHEMIE LTD (FACTORY B -INJECTABLE FACILITY)
  • ZHUHAI UNITED LABORATORIES CO, LTD. (intermediate 5:1 mixture)

Manufacturing country/countries: CYPRUS; CHINA

Source for this answer

Where can I look up MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17446P or the exact product name MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL. The general register link does not preselect this product.

Source for this answer

What are the source dates for this MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17446P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page